Trial Profile
AMG 714 Expanded Access Program
Status:
Recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Ordesekimab (Primary)
- Indications Coeliac disease
- Focus Expanded access; Therapeutic Use
- Sponsors Amgen
- 23 Feb 2018 New trial record